Compounds > propranolol
Page last updated: 2024-11-03

propranolol and Angiomatosis Retinae

propranolol has been researched along with Angiomatosis Retinae in 4 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research Excerpts

ExcerptRelevanceReference
"HeLa 9X (HRE) hypoxia responsive element cell line and primary hemangioblastoma-derived cells were subjected to propranolol treatment and cell viability and apoptosis were evaluated."7.81Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients. ( Albiñana, V; Botella, LM; de Campos, JM; Mota-Pérez, M; Perona-Moratalla, AB; Segura, T; Serrano-Heras, G; Villar Gómez de Las Heras, K, 2015)
"Propranolol was initiated with a progressive increase up to a final dose of 120 mg daily."5.46Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease. ( Albiñana, V; Botella, LM; Escribano, RMJ; Padial, LR; Recio-Poveda, L; Soler, I; Villar Gómez de Las Heras, K, 2017)
"HeLa 9X (HRE) hypoxia responsive element cell line and primary hemangioblastoma-derived cells were subjected to propranolol treatment and cell viability and apoptosis were evaluated."3.81Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients. ( Albiñana, V; Botella, LM; de Campos, JM; Mota-Pérez, M; Perona-Moratalla, AB; Segura, T; Serrano-Heras, G; Villar Gómez de Las Heras, K, 2015)
"Propranolol was initiated with a progressive increase up to a final dose of 120 mg daily."1.46Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease. ( Albiñana, V; Botella, LM; Escribano, RMJ; Padial, LR; Recio-Poveda, L; Soler, I; Villar Gómez de Las Heras, K, 2017)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Albiñana, V3
Recio-Poveda, L2
González-Peramato, P1
Martinez-Piñeiro, L1
Botella, LM3
Cuesta, AM1
Escribano, RMJ1
Soler, I1
Padial, LR1
Villar Gómez de Las Heras, K2
Karimi, S1
Nikkhah, H1
Ahmadieh, H1
Safi, S1
Serrano-Heras, G1
Segura, T1
Perona-Moratalla, AB1
Mota-Pérez, M1
de Campos, JM1

Other Studies

4 other studies available for propranolol and Angiomatosis Retinae

ArticleYear
Blockade of β2-Adrenergic Receptor Reduces Inflammation and Oxidative Stress in Clear Cell Renal Cell Carcinoma.
    International journal of molecular sciences, 2022, Jan-25, Volume: 23, Issue:3

    Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Hemangiobl

2022
Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease.
    Orphanet journal of rare diseases, 2017, 06-29, Volume: 12, Issue:1

    Topics: Adolescent; Adult; Biomarkers; Female; Hemangioblastoma; Humans; Male; MicroRNAs; Middle Aged; Propr

2017
INTRAVITREAL INJECTION OF PROPRANOLOL FOR THE TREATMENT OF RETINAL CAPILLARY HEMANGIOMA IN A CASE OF VON HIPPEL-LINDAU.
    Retinal cases & brief reports, 2020,Fall, Volume: 14, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Electroretinography; Fluorescein Angiography; Hemangioma, Capill

2020
Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.
    Orphanet journal of rare diseases, 2015, Sep-22, Volume: 10

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Apoptosis; Cell Survival; Cerebellar Neoplasms; Dose

2015